Mutational Landscape and Actionable Target Rates on Advanced Stage Refractory Cancer Patients: A Multicenter Chilean Experience.
Cordova-Delgado M, Pinto MP, Regonesi C, Cereceda L, Reyes JM, Itriago L, Majlis A, Rodríguez P, Fassler A, Mahave M, León ME, Gallardo J, Rodríguez Z MP, Berkovits A, Manque P, Ríos JA, Garcia-Bloj B, Garrido M.
Cordova-Delgado M, et al.
J Pers Med. 2022 Jan 31;12(2):195. doi: 10.3390/jpm12020195.
J Pers Med. 2022.
PMID: 35207683
Free PMC article.